Bairong Xia, Wenju Peng, Yao Chen, Wulin Shan, Wenjing Jiang, Wei Xiong. "A prospective, single-arm, phase 2 trial exploring the use of pamiparib combined with surufatinib as neoadjuvant therapy for advanced, unresectable ovarian cancer (PASSION).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5589